Baird's fifth private equity investment of 2020 is in life sciences consulting firm

Blue Matter provides consultancy services to the global pharmaceuticals sector.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.